Numinus Sees Integrated VC, MAPS Lead $6.0 Million Funding Round
Numinus Wellness (TSX: NUMI) has received a major vote of confidence, announcing last night that it will be conducting a
Read moreNuminus Wellness (TSX: NUMI) has received a major vote of confidence, announcing last night that it will be conducting a
Read moreNuminus Wellness (TSX: NUMI) is reporting this morning that it has sold its interest in Alto Neuroscience, a clinical-stage biopharma
Read moreConsolidation within the psychedelics space is getting underway, with the announcement this morning that Numinus Wellness (TSX: NUMI) will be
Read moreNuminus Wellness Inc. (TSXV: NUMI) announced on Thursday that its Chief Strategy Officer Stacey Wallin is leaving the company. The
Read moreNuminus Wellness (TSV: NUMI) is set to be one of the next firms listed on the Toronto Stock Exchange. The
Read moreLast week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after they produced an industry primer
Read moreNuminus Wellness Inc. (TSXV: NUMI) announced today that it has secured approval from Health Canada to conduct its feasibility study
Read moreEight Capital recently produced a primer on the psychedelic sector saying that the companies are “poised to fill a growing
Read moreNuminus Wellness (TSXV: NUMI) is undertaking further studies of its psilocybin products. The company this morning announced a partnership with
Read moreNuminus Wellness (TSXV: NUMI) this morning announced that it will be raising funds again. The latest round being conducted by
Read more